✦ LIBER ✦

Hormone receptors in male breast carcinoma

✍ Scribed by Stanley J. Ruff; John E. Bauer; Edward J. Keenan; H. Stephens Moseley; William S. Fletcher

Publisher: John Wiley and Sons
Year: 1981
Tongue: English
Weight: 310 KB
Volume: 18
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.2930180109

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Male breast carcinoma

✍ Leslie L. Alexander; David L. Benninghoff; Marvin F. Loring 📂 Article 📅 1977 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Estrogen receptors in male breast cancer

✍ Naveen Gupta; Joseph L. Cohen; Charles Rosenbaum; Shanthi Raam 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 2 views

Hormone receptors in renal cell carcinom

Hormone receptors in renal cell carcinoma

✍ John Pearson; Michael A. Friedman; Philip G. Hoffman 📂 Article 📅 1981 🏛 Springer 🌐 English ⚖ 309 KB

We have performed 23 estrogen and 24 progesterone receptor assays on tumor specimens from 26 patients with renal cancer, ten of whom subsequently received hormonal therapy for metastatic disease. Only one of these specimens contained measurable estrogen receptor levels, three contained low, but meas

Hormone receptors in rapidly progressing

Hormone receptors in rapidly progressing breast cancer

✍ Paul H. Levine; Francoise Tabbane; Larry R. Muenz; Lakshmi S. Kamaraju; Saroj Da 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB 👁 2 views

Familial male breast carcinoma

✍ Joseph G. Demeter; Norton G. Waterman; Gerald D. Verdi 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB 👁 2 views

Regional heterogeneity in breast carcino

Regional heterogeneity in breast carcinoma: Thymidine labelling index, steroid hormone receptors, dna ploidy

✍ John S. Meyer; James L. Wittliff 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 938 KB

We examined multiple samples of 65 primary breast carcinomas larger than I cm in diameter for thymidine labelling index (TLI), DNA index (DNAI, a measure of cellular DNA content by flow cytometry), and estrogen (ER) and progesterone (PgR) receptors by radioligand-binding. One or more axillary metast